Tag: virus-like particle (VLP)
Company Announces First Patient Dosing with Peanut Allergy Vaccine
PROTECT Trial is evaluating the safety and tolerability of VLP Peanut.
FDA Clears Path for Human Clinical Trials of Peanut Allergy Vaccine
"Virus Like Particle" based vaccine promises short-course treatment providing long-term protection.
Peanut Allergy Vaccine Takes Another Step with Biomarker Study
Study will help establish the starting dose of its vaccine candidate for a subsequent in-human phase I study.
Allergy Therapeutics Publishes Encouraging New Data for Peanut Allergy Vaccine Candidate
"This study indicates a paradigm shift by addressing peanut allergy via a vaccination concept instead of classic desensitisation..."
